Epstein Secrets

on Monday that he will leave his post on Inauguration Day. According to the AP, Pai has "presided over a contentious FCC over the last four years." Axios <https://vvww.axiostoin/fcc-chairman-pai-to-depart-in-january-b9254ecc-8866- 4051-926b-cbc9f42437a5.html> (11/30, McGill, 521K) reports, "Pai repeale

s://www.reuters.com/article/us-health-coronavirus-vaccines-modema/modema-files-for- u-s-vaccine-authorization-will-seek-eu-nod-idUSKEN28AIIU> (11/30, Steenhuysen, Erman) reports the FDA "said an advisory committee would meet to discuss the request on Dec. 17, making Modema's candidate the second highly effec

y encouraged there's been hours and hours every day of talks. And I'm really hopeful that we can get something done in the weeks ahead, not months." Axios (5/25, Knutson, 1.26M) reports the legislation is "stalled in the Senate due to Republican opposition to certain provisions, including curbing qual

, Neergaard) reports that Pfizer and Moderna "have begun testing in even younger children, from age 11 down to 6- month-old babies." Reuters (5/25, Steenhuysen) reports that FDA regulators "took about a month to review a similar study from Pfizer/BioNtech, which was authorized for ages 12-15 on May 10." The

nate Minority Leader Schumer. So "whatever this collection of senators can achieve is likely to be modest, if they can accomplish anything at all." Axios (11/30, Treene, 521K) says "most lawmakers still see only a small chance for passage of a comprehensive stimulus package before the end of the year

ow applying for Emergency Vaccine Approval.. @US_FDA MUST ACT QUICKLY!!! Operation Warp Speed has been a great modern day miracle." Reuters (11/30, Steenhuysen, Erman) reports the FDA "said an advisory committee would meet to discuss the request on Dec. 17, making Moderna's candidate the second highly effe

y 2, 2:20, O'Donnell, 4.46M) reported, "The ripple effect is already putting the new season in question." Cain Still Hospitalized For Coronavirus. Axios (7/27, Fernandez, 521K) reports, "Former Republican presidential candidate Herman Cain is still in the hospital undergoing oxygen treatment more tha

ld have tremendous bandwidth to manufacture at scale." Global Alliance Says Vaccine Should Cost No More Than $40 Per Shot. Reuters (7/27, Kelland, Steenhuysen) reports that "coordinators of a global coronavirus vaccines funding scheme are looking at a wide range of potential prices for COVID-19 shots, with

y encouraged there's been hours and hours every day of talks. And I'm really hopeful that we can get something done in the weeks ahead, not months." Axios (5/25, Knutson, 1.26M) reports the legislation is "stalled in the Senate due to Republican opposition to certain provisions, including curbing qual

5, Neergaard) reports that Pfizer and Moderna "have begun testing in even younger children, from age 11 down to 6-month-old babies." Reuters (5/25, Steenhuysen) reports that FDA regulators "took about a month to review a similar study from Pfizer/BioNtech, which was authorized for ages 12-15 on May 10." The

y 2, 2:20, O'Donnell, 4.46M) reported, "The ripple effect is already putting the new season in question." Cain Still Hospitalized For Coronavirus. Axios (7/27, Fernandez, 521K) reports, "Former Republican presidential candidate Herman Cain is still in the hospital undergoing oxygen treatment more tha

ld have tremendous bandwidth to manufacture at scale." Global Alliance Says Vaccine Should Cost No More Than $40 Per Shot. Reuters (7/27, Kelland, Steenhuysen) reports that "coordinators of a global coronavirus vaccines funding scheme are looking at a wide range of potential prices for COVID-19 shots, with

nate Minority Leader Schumer. So "whatever this collection of senators can achieve is likely to be modest, if they can accomplish anything at all." Axios (11/30, Treene, 521K) says "most lawmakers still see only a small chance for passage of a comprehensive stimulus package before the end of the year

ow applying for Emergency Vaccine Approval.. @US_FDA MUST ACT QUICKLY!!! Operation Warp Speed has been a great modern day miracle." Reuters (11/30, Steenhuysen, Erman) reports the FDA "said an advisory committee would meet to discuss the request on Dec. 17, making Moderna's candidate the second highly effe